AlTi Global, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
NEW YORK–(BUSINESS WIRE)–AlTi Global, Inc. (NASDAQ: ALTI) (“AlTi” or the “Company”), a leading independent global wealth and alternatives... Read more.
Calidi Biotherapeutics Reports Fourth Quarter and Full-Year 2023 Operating and Financial Results
City of Hope, a leader in cancer research and treatment, was awarded $5.3 million from California Institute for Regenerative Medicine (CIRM) to develop a treatment... Read more.
OFS Credit Company Provides February 2024 Net Asset Value Update
CHICAGO–(BUSINESS WIRE)–OFS Credit Company, Inc. (NASDAQ: OCCI) (“OFS Credit”, the “Company”, “we”, “us” or “our”), an investment... Read more.
California University of Science and Medicine Celebrates Match Day for 2024 MD Graduates
Nearly 80 percent to join residency programs in California; 33 percent in the Inland Empire COLTON, Calif.–(BUSINESS WIRE)–California University of Science... Read more.
KBRA Assigns AA Rating, Stable Outlook to State of Louisiana General Obligation Bonds Series 2024-A and Refunding Series 2024-B; Affirms Rating for Parity Bonds
NEW YORK–(BUSINESS WIRE)–#creditratingagency–KBRA assigns a long-term rating of AA with a Stable Outlook to the State of Louisiana General Obligation... Read more.
AM Best to Participate in Panel Discussion at Annual IFRS 17 Conference in London
LONDON–(BUSINESS WIRE)–#insurance—AM Best will participate in a panel discussion at the annual IFRS 17 Conference, hosted by InsuranceERM, to be... Read more.
MeridianLink Inc. (MLNK) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
NEW YORK–(BUSINESS WIRE)–$MLNK #classaction–Attorney Advertising–Bronstein, Gewirtz & Grossman, LLC is investigating potential claims... Read more.
Revitalizing a 71-mile Gem: High Line Canal Conservancy Unveils Great Lengths Campaign Following GOCO Award
DENVER–(BUSINESS WIRE)–Today, the High Line Canal Conservancy announces Great Lengths for the High Line, a $33 million campaign poised to revitalize... Read more.
CARVYKTI® (ciltacabtagene autoleucel) Receives Recommendation from the U.S. FDA Oncologic Drugs Advisory Committee for Earlier Treatment of Patients with Relapsed/Refractory Multiple Myeloma
FDA ODAC votes 11 to 0 supporting favorable risk-benefit assessment of CARVYKTI based on results from the Phase 3 CARTITUDE-4 study SOMERSET, N.J.–(BUSINESS... Read more.
Farmers Edge Shareholders Approve Plan of Arrangement with Fairfax
WINNIPEG, Manitoba–(BUSINESS WIRE)–Farmers Edge Inc. (“Farmers Edge” or the “Company”) (TSX: FDGE) announced today that the previously announced... Read more.